These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Clinical evaluation of twice-daily emedastine 0.05% eye drops (Emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis. Verin P, Easty DL, Secchi A, Ciprandi G, Partouche P, Nemeth-Wasmer G, Brancato R, Harrisberg CJ, Estivin-Ebrardt C, Coster DJ, Apel AJ, Coroneo MT, Knorr M, Carmichael TR, Kent-Smith BT, Abrantes P, Leonardi A, Cerqueti PM, Modorati G, Martinez M. Am J Ophthalmol; 2001 Jun; 131(6):691-8. PubMed ID: 11384563 [Abstract] [Full Text] [Related]
7. To evaluate the efficacy and safety of olopatadine 0.1% ophthalmic solution and bepotastine 1.5% ophthalmic solution in patients with vernal keratoconjunctivitis in a tertiary care hospital. Sruthi V, Reddy RN, Sowmini K, Grace NS. Indian J Pharmacol; 2020 Jun; 52(6):476-481. PubMed ID: 33666188 [Abstract] [Full Text] [Related]
16. Azelastine eye drops in the treatment of seasonal allergic conjunctivitis or rhinoconjunctivitis in young children. Sabbah A, Marzetto M. Curr Med Res Opin; 1998 Sep; 14(3):161-70. PubMed ID: 9787982 [Abstract] [Full Text] [Related]
17. Treatment of common ocular allergic disorders; a comparison of lodoxamide and NAAGA. Denis D, Bloch-Michel E, Verin P, Sebastiani A, Tazartes M, Helleboid L, Di Giovanni A, Lecorvec M. Br J Ophthalmol; 1998 Oct; 82(10):1135-8. PubMed ID: 9924299 [Abstract] [Full Text] [Related]
18. [Comparison of three antiallergic eyedrops in a specific conjunctival provocation test: mequitazine, levocabastine and dexamethasone]. Richard C, Bibas P, Lablache-Combier M, Allaire C. J Fr Ophtalmol; 2005 Mar; 28(3):244-50. PubMed ID: 15883488 [Abstract] [Full Text] [Related]